Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$43.41 - $56.51 $2.37 Million - $3.09 Million
-54,626 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$47.43 - $60.75 $2.7 Million - $3.46 Million
-57,000 Reduced 51.06%
54,626 $2.65 Million
Q2 2020

Aug 10, 2020

SELL
$43.51 - $66.59 $43 - $66
-1 Reduced -0.0%
111,626 $6.21 Million
Q1 2020

May 11, 2020

BUY
$32.82 - $81.13 $2.56 Million - $6.34 Million
78,104 Added 232.99%
111,627 $5.66 Million
Q4 2019

Feb 10, 2020

BUY
$60.96 - $77.7 $1.84 Million - $2.34 Million
30,113 Added 883.08%
33,523 $2.59 Million
Q3 2019

Nov 13, 2019

BUY
$55.78 - $68.08 $190,209 - $232,152
3,410 New
3,410 $216,000
Q2 2019

Aug 13, 2019

SELL
$53.69 - $65.47 $236,772 - $288,722
-4,410 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$44.53 - $58.9 $44 - $58
1 Added 0.02%
4,410 $0
Q4 2018

Feb 11, 2019

BUY
$47.64 - $71.26 $210,044 - $314,185
4,409 New
4,409 $218,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.